drug protocol number

CAMN107E2401

drug sponsor

Novartis

drug study

Nilotinib

drug trial site

King Fahad Specialist Hospital (Dammam), King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah), King Abdulaziz Medical City NG (Jeddah), King Abdulaziz Hospital and Oncology Center (Jeddah)

drug status

Completed

drug phase